Skip to main content
. Author manuscript; available in PMC: 2018 Jan 29.
Published in final edited form as: Curr Drug Discov Technol. 2017;14(3):156–168. doi: 10.2174/1570163814666170330100238

Table 3.

Minimum inhibitory concentration of the hit compound against clinically important bacterial.

Bacteria Isopomiferin
E. coli (ATCC 25922) 128a
E. coli tolC (efflux mutant) 64
E. faecalis (ATCC 29212) 32
H. influenzae (ATCC 49766) 32
P. aeruginosa (ATCC 47085) 128
P. aeruginosa PAO200 (efflux mutant) 128
P. aeruginosa (hypersensitive) 16
S. aureus (ATCC 29213) 32
S. pneumoniae (ATCC 49619) >128
a

The MIC (μg/ml) against each of the bacteria was determined in three separate sets of assays.